BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8841545)

  • 1. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
    Isomura M; Sugiyama H; Saito I
    Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative alkylation by duocarmycin A-distamycin A heterodimer.
    Ozeki Y; Sugiyama H; Saito I
    Nucleic Acids Symp Ser; 1997; (37):91-2. PubMed ID: 9586014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerted DNA recognition and novel site-specific alkylation by duocarmycin A with distamycin A.
    Yamamoto K; Sugiyama H; Kawanishi S
    Biochemistry; 1993 Feb; 32(4):1059-66. PubMed ID: 8424935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of the covalent duocarmycin A-DNA duplex complex.
    Lin CH; Patel DJ
    J Mol Biol; 1995 Apr; 248(1):162-79. PubMed ID: 7731041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site specific covalent alkylation of DNA by antitumor antibiotics, duocarmycin A and kapurimycin A3.
    Sugiyama H; Lam CK; Hosoda M; Saito I
    Nucleic Acids Symp Ser; 1991; (25):75-6. PubMed ID: 1842103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distamycin A modulates the sequence specificity of DNA alkylation by duocarmycin A.
    Sugiyama H; Lian C; Isomura M; Saito I; Wang AH
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14405-10. PubMed ID: 8962064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distamycin A enhances the cytotoxicity of duocarmycin A and suppresses duocarmycin A-induced apoptosis in human lung carcinoma cells.
    Hirota M; Fujiwara T; Mineshita S; Sugiyama H; Teraoka H
    Int J Biochem Cell Biol; 2007; 39(5):988-96. PubMed ID: 17321782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the calicheamicin gamma 1I-DNA complex.
    Kumar RA; Ikemoto N; Patel DJ
    J Mol Biol; 1997 Jan; 265(2):187-201. PubMed ID: 9020982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High resolution solution structure of a DNA duplex alkylated by the antitumor agent duocarmycin SA.
    Eis PS; Smith JA; Rydzewski JM; Case DA; Boger DL; Chazin WJ
    J Mol Biol; 1997 Sep; 272(2):237-52. PubMed ID: 9299351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size.
    Brooks N; McHugh PJ; Lee M; Hartley JA
    Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis for in situ activation of DNA alkylation by duocarmycin SA.
    Smith JA; Bifulco G; Case DA; Boger DL; Gomez-Paloma L; Chazin WJ
    J Mol Biol; 2000 Jul; 300(5):1195-204. PubMed ID: 10903864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
    McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
    Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.
    Sunavala-Dossabhoy G; Van Dyke MW
    Biochemistry; 2005 Feb; 44(7):2510-22. PubMed ID: 15709763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkylation of duplex DNA in nucleosome core particles by duocarmycin SA and yatakemycin.
    Trzupek JD; Gottesfeld JM; Boger DL
    Nat Chem Biol; 2006 Feb; 2(2):79-82. PubMed ID: 16415862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modelling of the interaction of carbocyclic analogues of netropsin and distamycin with d(CGCGAATTCGCG)2.
    Bielawski K; Bielawska A; Bartulewicz D; Rózański A
    Acta Biochim Pol; 2000; 47(3):855-66. PubMed ID: 11310985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polybenzamide mustards: structure-activity relationships for DNA sequence-specific alkylation.
    Turner PR; Ferguson LR; Denny WA
    Anticancer Drug Des; 1999 Feb; 14(1):61-70. PubMed ID: 10363028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
    Gupta R; Liu J; Xie G; Lown JW
    Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry of drug-induced DNA lesions.
    Saito I
    Toxicol Lett; 1993 Apr; 67(1-3):3-15. PubMed ID: 8451767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
    Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
    Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin.
    Broggini M; Coley HM; Mongelli N; Pesenti E; Wyatt MD; Hartley JA; D'Incalci M
    Nucleic Acids Res; 1995 Jan; 23(1):81-7. PubMed ID: 7870593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.